Clinical Trials

Showing trials with last updates posted in 2026.

NCT04157049 | RECRUITING
5000 participants

Alpha-1 Research Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-19
Start Date:
2019-06-20
Completion:
2029-06-20
Conditions
  • Alpha 1-Antitrypsin Deficiency
No Results Yet
NCT04104776 | RECRUITING | PHASE1/PHASE2
300 participants

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2019-09-18
Completion:
2030-02-27
Conditions
  • Advanced Solid Tumor
  • Diffuse Large B Cell Lymphoma
  • Lymphoma, T-Cell
  • Mesothelioma, Malignant
  • Prostatic Neoplasms, Castration-Resistant
  • Endometrial Cancer
  • Ovarian Clear Cell Carcinoma
  • Metastatic Castration-resistant Prostate Cancer
Interventions
  • DRUG
No Results Yet
NCT04092283 | ACTIVE_NOT_RECRUITING | PHASE3
660 participants

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2020-04-29
Completion:
2028-12-31
Conditions
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Unresectable Lung Non-Small Cell Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT03740165 | COMPLETED | PHASE3
1367 participants

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2018-12-18
Completion:
2024-08-26
Conditions
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Neoplasms
Interventions
  • BIOLOGICAL
  • DRUG
NCT03604315 | RECRUITING | PHASE1
300 participants

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2018-12-18
Completion:
2027-06-30
Conditions
  • Breast Carcinoma
  • Fallopian Tube Carcinoma
  • Ovarian Carcinoma
  • Primary Peritoneal Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Solid Neoplasm
Interventions
  • PROCEDURE
  • RADIATION
No Results Yet
NCT03493425 | ACTIVE_NOT_RECRUITING | PHASE2
82 participants

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2019-03-12
Completion:
2029-03-31
Conditions
  • Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
Interventions
  • DRUG
  • RADIATION
  • OTHER
  • PROCEDURE
No Results Yet
NCT03147612 | ACTIVE_NOT_RECRUITING | PHASE2
22 participants

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2018-02-08
Completion:
2027-02-28
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia With BCR-ABL1
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Recurrent Acute Lymphoblastic Leukemia
  • Refractory Acute Lymphoblastic Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page